Whole-Brain Radiotherapy Can Improve the Survival of Patients with Multiple Brain Metastases from Non-Small Cell Lung Cancer Treated by Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors.

Cheng ChenYan WuBao Ling LiuHong Wei WangJian Hua MaJu Ying Zhou

Published in: Cancer management and research (2020)

WBRT can improve the survival of patients with multiple BM from NSCLC receiving EGFR-TKI targeted therapy and is an independent prognostic factor. The choice of RT time has no effect on patient survival.

Keyphrases

epidermal growth factor receptor
brain metastases
small cell lung cancer
advanced non small cell lung cancer
tyrosine kinase
prognostic factors
free survival
early stage
radiation therapy
case report
newly diagnosed